fr | en

Liminib or Pyr1

Target nature : Lim Kinase
CAS n° : 83947-94-8
Mecanism of action : Enzymatic inhibition
Physico-chemical properties : Molecular weight 382.41 g.mol-1
Probe availability : Chimiothèque Institut Curie-CNRS
Princeps reference : WO2010095042 Cancer Research 2012, 72(17):4429-39. DOI: 10.1158/0008-5472.CAN-11-3342
More bibliography : Cancer Research 2010, 70, 9865 DOI:10.1158/0008-5472.CAN-10-0917
Other available information on the probe : 9-Benzoyloxy-5, 11-demethyl-2H,6Hpyrido[4,3-b]carbazol-1-one
Other information on the target : Kinase regulating cytoskeleton networks (actin, microtubule)
Selectivity profile : Tested on a 66 kinase panel involved in the regulation of the cytoskeleton. Only activ on NEK11 and MLK1 and LIMK1 (the highest inhibition) & LIMK2.Tested on 45 additional different kinases (ATP-competitive kinase inhibition): no significant interaction.
In vivo data : 10 mg/kg/d in PEG400 IP for 10 days on tumor xenograft models (leukemia L1210) on B6D2F1 female mice: well tolerated, good therapeutic efficacy
In vitro data : IC50 (LIMK1)= 50nM & IC50(LIMK2)=75nM
Toxicity : not described
Chaine SMILES : Cc4c1cc[nH]c(=O)c1c(C)c5c3cc(OC(=O)c2ccccc2)ccc3[nH]c45
Contacter l'auteur de la sonde